Interventional pain management company Minrad International posted slightly lower revenues for its second quarter (end-June 30), which it attributed to production limitations resulting from the temporary shutdown of its sevoflurane line for cleaning and maintenance, delays in the receipt of raw materials, and the disc rupture of one of the company's production reactors.
The Orchard Park, NY-based company reported revenues of $4.2 million for the second quarter of 2008, down 4% compared to $4.3 million in the second quarter of 2007.
Net loss for the second quarter of 2008 was $11.7 million, a 70% increase compared to a net loss of $3.4 million in the second quarter of 2007.
Related Reading
Minrad makes two exec appointments, January 15, 2008
Minrad expands revenue and loss, August 16, 2007
Minrad nets CE Mark, September 11, 2006
Minrad names European, Latin America directors, July 20, 2006
Minrad revenues rise, April 18, 2006
Copyright © 2008 AuntMinnie.com
